Navigating the challenge of patient selection and scales to measure outcomes in ketamine trials for treatment-resistant depression

Sarah Pereira Gomes; Sofia Rodrigues Lima; Fabio Gomes de Matos Souza; Luísa Weber Bisol

doi:10.1177/02698811241276505

Navigating the challenge of patient selection and scales to measure outcomes in ketamine trials for treatment-resistant depression

J Psychopharmacol. 2024 Sep 12:2698811241276505. doi: 10.1177/02698811241276505. Online ahead of print.

Authors

Sarah Pereira Gomes¹, Sofia Rodrigues Lima², Fabio Gomes de Matos Souza³, Luísa Weber Bisol¹

Affiliations

¹ Federal University of Ceara, Fortaleza, Ceará, Brazil.
² University of Fortaleza, Fortaleza, Brazil.
³ Federal University of Ceará Walter Cantídio Teaching Hospital, Fortaleza, Brazil.

PMID: 39263775
DOI: 10.1177/02698811241276505

Abstract

The letter about the article "Ketamine for treatment-resistant major depressive disorder: Double-blind active-controlled crossover study" that discusses some points about methodology, outcome measures, and results.

Keywords: TRD; ketamine; scales.

Publication types

Letter